Microvascular and Macrovascular Complications of Diabetes
Abstract
in an eight-part series reviewing the fundamentals of diabetes care for phy-sicians in training. Previous articles in the series can be viewed at the Clinical Diabetes website
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In people with T2DM who discontinue or do not properly adhere to their therapy, there is an increased risk of microvascular and macrovascular complications, which can in turn increase healthcare costs further.
“In people with T2DM who discontinue or do not properly adhere to their therapy, there is an increased risk of microvascular and macrovascular complications [7], which can in turn increase healthcare costs further [5, 6].”
Lack of adherence and persistence with treatment in T2DM increases the risk of microvascular and macrovascular complications.
“Lack of adherence and persistence with treatment in T2DM acts as a barrier to achieving glycaemic control [6], increases the risk of microvascular and macrovascular complications [7], and increases healthcare costs [5, 8].”
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419 · see citing works
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000 · see citing works
Lang, G. E., Vaiser, A., Snyder, W. B., & Lynn, J. R. (1974) · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583 · see citing works
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407 · see citing works
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138 · see citing works
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803 · see citing works
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147 · see citing works
Diabetes and cardiovascular disease. The Framingham study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.241.19.2035 · Cited by 3,958 · see citing works
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · see citing works
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755 · see citing works
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,723 · see citing works
(2000) · PubMed · Cited by 2,095 · see citing works
Turner, R. D., & Holman, R. R. (1998) · Cited by 1,973 · see citing works
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859 · see citing works
Diabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839 · see citing works
Adler, A., Stevens, R., Manley, S. E., Bilous, R., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,800 · see citing works
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B., et al. (1998) · BMJ · doi:10.1136/bmj.317.7160.713 · Cited by 1,784 · see citing works
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560 · see citing works
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 1,406 · see citing works
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L. M., Ferrara, N., King, G. L., & Smith, L. E. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,258 · see citing works
Standards of Medical Care in Diabetes—2007
American Diabetes Association (2007) · Diabetes Care · doi:10.2337/dc07-s004 · Cited by 1,190 · see citing works
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055 · see citing works
Abbott, C. A., Carrington, A. L., Ashe, H., Bath, S., Every, L. C., Griffiths, J., Hann, A. W., Hussein, A., Jackson, N., Johnson, K. E., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00698.x · Cited by 1,054 · see citing works
Gardner, C. D., Kiazand, A., Alhassan, S., Kim, S., Stafford, R. S., Balise, R. R., Kraemer, H. C., & King, A. C. (2007) · JAMA · doi:10.1001/jama.297.9.969 · Cited by 1,051 · see citing works
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
Manninen, V. (1988) · JAMA · doi:10.1001/jama.1988.03410050061031 · Cited by 954 · see citing works
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
Laing, S. P., Swerdlow, A. J., Slater, S. D., Burden, A. C., Morris, A., Waugh, N. R., Gatling, W., Bingley, P. J., & Patterson, C. C. (2003) · Diabetologia · doi:10.1007/s00125-003-1116-6 · Cited by 724 · see citing works
Fong, D. S., Aiello, L. P., Ferris, F. L., & Klein, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2540 · Cited by 694 · see citing works
Maser, R. E., Mitchell, B. D., Vinik, A. I., & Freeman, R. L. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1895 · Cited by 678 · see citing works
Almdal, T., Scharling, H., Jensen, J. S., & Vestergaard, H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1422 · Cited by 650 · see citing works
Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study
Koskinen, P., Mänttäri, M., Manninen, V., Huttunen, J. K., Heinonen, O. P., & Frick, M. H. (1992) · Diabetes Care · doi:10.2337/diacare.15.7.820 · Cited by 509 · see citing works
Aliello, L. P. (1995) · Medical Entomology and Zoology · Cited by 463 · see citing works
Rader, D. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.003 · Cited by 345 · see citing works
Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus
Gabbay, K. H. (1975) · Annual Review of Medicine · doi:10.1146/annurev.me.26.020175.002513 · Cited by 329 · see citing works
Predictors of Stroke in Middle-Aged Patients With Non–Insulin-Dependent Diabetes
Lehto, S., Rönnemaa, T., Pyörälà, K., & Laakso, M. (1996) · Stroke · doi:10.1161/01.str.27.1.63 · Cited by 227 · see citing works
Rossing, K., Jacobsen, P. K., Pietraszek, L., & Parving, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2268 · Cited by 224 · see citing works
Keenan, H. A., Costacou, T., Sun, J. K., Doria, A., Cavallerano, J. D., Coney, J., Orchard, T. J., Aiello, L. P., & King, G. L. (2007) · Diabetes Care · doi:10.2337/dc06-2222 · Cited by 196 · see citing works
Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
Chaturvedi, N., Bandinelli, S., Mangili, R., Penno, G., Rottiers, R. E., & Fuller, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00789.x · Cited by 191 · see citing works
Predictors of Stroke in Middle-Aged Patients With Non–Insulin-Dependent Diabetes
SeppoLehto, TapaniRönnemaa, KaleviPyörälä, & MarkkuLaakso (1996) · Stroke · Cited by 187 · see citing works
Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women
Avogaro, A., Giorda, C. B., Maggini, M., Mannucci, E., Raschetti, R., Lombardo, F. L., Alegiani, S. S., Turco, S., Velussi, M., & Ferrannini, E. (2007) · Diabetes Care · doi:10.2337/dc06-2558 · Cited by 169 · see citing works
Kunisaki, M., Bursell, S., Clermont, A. C., et al. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.2.e239 · Cited by 156 · see citing works
The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM
Markovic, T. P., Jenkins, A. B., Campbell, L. V., Furler, S. M., Kraegen, E. W., & Chisholm, D. J. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.687 · Cited by 154 · see citing works
Diabetes Mellitus and Macrovascular Disease: Mechanisms and Mediators
Boyle, P. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.07.003 · Cited by 147 · see citing works
Watkins, P. J. (2003) · BMJ · doi:10.1136/bmj.326.7395.924 · Cited by 136 · see citing works
Mortality From Cerebrovascular Disease in a Cohort of 23 000 Patients With Insulin-Treated Diabetes
Laing, S. P., Swerdlow, A. J., Carpenter, L. M., Slater, S. D., Burden, A. C., Botha, J. L., Morris, A. D., Waugh, N. R., Gatling, W., Gale, E. A., et al. (2003) · Stroke · doi:10.1161/01.str.0000053843.03997.35 · Cited by 131 · see citing works
The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes
Paterson, A. D., Rutledge, B. N., Cleary, P. A., Lachin, J. M., Crow, R. S., & for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2007) · Diabetes Care · doi:10.2337/dc06-1441 · Cited by 81 · see citing works
Aldose reductase inhibition in the treatment of diabetic neuropathy: Where are we in 2004?
Gabbay, K. H. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0047-z · Cited by 53 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases
Nandi, A., Yan, L.-J., Jana, C. K., & Das, N. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9613090 · Cited by 1,185 · see citing works
Inflammatory Markers and Risk of Type 2 Diabetes
Wang, X., Bao, W., Liu, J., OuYang, Y.-Y., Wang, D., Rong, S., Xiao, X., Shan, Z.-L., Zhang, Y., Yao, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0702 · Cited by 820 · see citing works
Human blood vessel organoids as a model of diabetic vasculopathy
Wimmer, R. A., Leopoldi, A., Aichinger, M., Wick, N., Hantusch, B., Novatchkova, M., Taubenschmid, J., Hämmerle, M., Esk, C., Bagley, J. A., et al. (2019) · Nature · doi:10.1038/s41586-018-0858-8 · Cited by 803 · see citing works
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H. (2022) · Circulation · doi:10.1161/cir.0000000000001040 · Cited by 660 · see citing works
Antidiabetic Properties of Dietary Flavonoids: A Cellular Mechanism Review
Vinayagam, R., & Xu, B. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0057-7 · Cited by 597 · see citing works
Global estimates of undiagnosed diabetes in adults
Beagley, J., Guariguata, L., Weil, C., & Motala, A. A. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.001 · Cited by 586 · see citing works
From pre-diabetes to diabetes: diagnosis, treatments and translational research
Khan, R., Chua, Z., Tan, J., Yang, Y., Liao, Z., & Zhao, Y. (2019) · Medicina · doi:10.3390/medicina55090546 · Cited by 484 · see citing works
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
Kawser Hossain, M., Abdal Dayem, A., Han, J., Yin, Y., Kim, K., Kumar Saha, S., Yang, G.-M., Choi, H., & Cho, S.-G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040569 · Cited by 495 · see citing works
Type 2 diabetes mellitus and psychological stress — a modifiable risk factor
Hackett, R. A., & Steptoe, A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.64 · Cited by 480 · see citing works
Yoga for Adults with Type 2 Diabetes: A Systematic Review of Controlled Trials
Innes, K. E., & Selfe, T. K. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6979370 · Cited by 248 · see citing works
Mitochondrial dysfunction and complications associated with diabetes
Blake, R., & Trounce, I. A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.007 · Cited by 190 · see citing works
Mamo, Y., Bekele, F., Nigussie, T., & Zewudie, A. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0421-0 · Cited by 147 · see citing works
Nielsen, S. F., & Nordestgaard, B. G. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70173-1 · Cited by 125 · see citing works
Application of microRNAs in diabetes mellitus
Chen, H., Lan, H.-Y., Roukos, D. H., & Cho, W. C. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0544 · Cited by 124 · see citing works
Toro-Ramos, T., Michaelides, A., Anton, M., Karim, Z., Kang-Oh, L., Argyrou, C., Loukaidou, E., Charitou, M. M., Sze, W., & Miller, J. D. (2020) · JMIR mHealth and uHealth · doi:10.2196/17842 · Cited by 107 · see citing works
G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
Riddy, D. M., Delerive, P., Summers, R. J., Sexton, P. M., & Langmead, C. J. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014373 · Cited by 108 · see citing works
Role of diet and exercise in aging, Alzheimer’s disease, and other chronic diseases
Khemka, S., Reddy, A., Garcia, R. I., Jacobs, M., Reddy, R. P., Roghani, A. K., Pattoor, V., Basu, T., Sehar, U., & Reddy, P. H. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102091 · Cited by 88 · see citing works
Bedenis, R., Price, A. H., Robertson, C. M., Morling, J. R., Frier, B. M., Strachan, M. W. J., & Price, J. F. (2014) · Diabetes Care · doi:10.2337/dc14-0908 · Cited by 87 · see citing works
Garg, V., Verma, S., & Connelly, K. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.07.005 · Cited by 82 · see citing works
Canagliflozin Inhibits Human Endothelial Cell Proliferation and Tube Formation
Behnammanesh, G., Durante, Z. E., Peyton, K. J., Martinez-Lemus, L. A., Brown, S. M., Bender, S. B., & Durante, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00362 · Cited by 61 · see citing works
The effects of omega-3 fatty acids in type 2 diabetes: A systematic review and meta-analysis
Xiao, Y., Zhang, Q., Liao, X., Elbelt, U., & Weylandt, K. H. (2022) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102456 · Cited by 50 · see citing works
Ofori‐Asenso, R., Sahle, B. W., Chin, K. L., Mazidi, M., Ademi, Z., De Bruin, M. L., & Liew, D. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3350 · Cited by 44 · see citing works
Sadosky, A., Hopper, J., & Parsons, B. (2014) · The Patient - Patient-Centered Outcomes Research · doi:10.1007/s40271-013-0038-8 · Cited by 42 · see citing works
Combination immunotherapy for type 1 diabetes
Bone, R. N., & Evans-Molina, C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0878-z · Cited by 41 · see citing works
Dorsey-Treviño, E. G., González-González, J. G., Alvarez-Villalobos, N., González-Nava, V., Contreras-Garza, B. M., Díaz González-Colmenero, A., Rodríguez-Tamez, G., Barrera-Flores, F. J., Farrell, A. M., Montori, V. M., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01103-9 · Cited by 39 · see citing works
Roborel de Climens, A., Pain, E., Boss, A., & Shaunik, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00843-9 · Cited by 38 · see citing works
McEwan, P., Morgan, A. R., Boyce, R., Bergenheim, K., Gause‐Nilsson, I. A. M., Bhatt, D. L., Leiter, L. A., Johansson, P. A., Mosenzon, O., Cahn, A., et al. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14308 · Cited by 34 · see citing works
Sambyal, N., Saini, P., & Syal, R. (2021) · Current Diabetes Reviews · doi:10.2174/1573399816666200511003357 · Cited by 19 · see citing works
Rowe, C. W., Watkins, B., Brown, K., Delbridge, M., Addley, J., Woods, A., & Wynne, K. (2021) · Diabetic Medicine · doi:10.1111/dme.14489 · Cited by 16 · see citing works
Yimam, M. A., Andreini, M., Carnevale, S., & Muscaritoli, M. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1461621 · Cited by 16 · see citing works
Battelino, T., Edelman, S. V., Nishimura, R., & Bergenstal, R. M. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0180 · Cited by 13 · see citing works
Kawaguchi, Y., Sawa, J., Hamai, C., Nishimura, Y., & Kumeda, Y. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13038 · Cited by 10 · see citing works
Coleman, C. I., Pandya, S., Wang, L., Baser, O., Cai, J., Ingham, M., & Bookhart, B. (2019) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2019-0002 · Cited by 10 · see citing works
Glucose-Lowering Medication Use in CKD: Analysis of US Medicare Beneficiaries Between 2007 and 2016
Zhao, J. Z., Weinhandl, E. D., Carlson, A. M., & St. Peter, W. L. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2020.09.016 · Cited by 9 · see citing works
Does the encounter type matter when defining diabetes complications in electronic health records?
Hong, D., Shen, Y., Monnette, A., Liu, S., Shao, H., Nauman, E., Price-Haywood, E., Hu, G., & Shi, L. (2020) · Medical Care · doi:10.1097/mlr.0000000000001297 · Cited by 4 · see citing works
- Authors
- Fowler, M. J.
- Corresponding author
- Fowler, Michael J.
- Venue
- Clinical Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-04-01
- Volume
- 26
- Issue
- 2
- Pages
- 77-82
- ISSN
- 0891-8929 (ISSN-L)
- 1945-4953
- OpenAlex
- W2126946832
- Cited by
- 1,954
- References
- 51
- Citations by year
- 2026: 72 · 2025: 104 · 2024: 129 · 2023: 166 · 2022: 125 · 2021: 176 · 2020: 187 · 2019: 170 · 2018: 145 · 2017: 134 · 2016: 144 · 2015: 116 · 2014: 110 · 2013: 77 · 2012: 43
- FWCI
- 12.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Diabetes (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- diabetes complications, microvascular complications, macrovascular complications, diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, cardiovascular disease in diabetes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
